Treatment strategies

Use of cytokines in HIV: colony-stimulating factors, erythropoietin, and interleukin-2

Structured treatment interruptions

Study shows immune system can control HIV: early antiviral treatment primes the immune system to suppress viral levels without drugs

Human IL-12 may augment HIV-specific immunity in HIV-positive patients

Structured treatment interruptions and treatment intensification

New developments in affordable antiretroviral therapy: intermittent treatment

Once-daily protease-based regimens

What is the significance of blips in viral load?

Phase III study of GM-CSF in advanced HIV disease

GM-CSF beneficial for patients with advanced HIV disease

French National Drug Agency re-commends use of IL-2 if HAART does not lead to an increase in CD4 count to greater than 200 cells/mm3

Post navigation